Lost Productivity Attributed to Neoplasms in South America

• Autor(a) principal: Mosegui, Gabriela Bittencourt Gonzalez
• Data de Publicação: 2023
• Outros Autores: Vianna, Cid Manso de Mello, Antoñanzas Villar, Fernando, Rodrigues, Marcus Paulo da Silva
• Tipo de documento: Artigo
• Idioma: por; eng; spa
• Título da fonte: Revista Brasileira de Cancerologia (Online)
• Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3289
• topic: efeitos psicossociais da doença; neoplasias; anos de vida ajustados pela incapacidade; América do Sul; cost of illness; neoplasms; disability-adjusted life years; South America; costo de enfermedad; neoplasias; años de vida ajustados por discapacidad; América del Sur

Introduction: The burden of the disease has been utilized in estimates of the impact of neoplasms, but the loss of productivity due to these diseases has not yet been explored. Objective: To estimate the years of productivity life lost (YPLL) and lost productivity due to premature cancer-related mortality in South American countries in 2019. Method: Mortality data available from Global Burden of Disease (GBD) Study 2019 was analyzed to estimate the burden attributable to neoplasms. The productivity loss in monetary terms was estimated using a proxy of the human capital approach (HCA). Calculations were performed by sex, in working age groups. Results: The total deaths and YPLL reached 192,240 and 2.463.155, respectively. The total permanent productivity loss was around US$ 4.4 billion and US$ 9.4 billion in purchasing power parity (PPP) – 0.13% of the continent’s gross domestic product (GDP). Total cost per death was US$23,617. There were significant differences among countries, but the variation of scenarios shows robustness of the estimates. Conclusion: Cancer imposes a significant economic burden on South American, both in terms of health and productivity. Its characterization can help governments to allocate resources for policies planning and health interventions.